Cindy L Jellis

Title: The Innovative Contributions of Cindy L Jellis

Introduction

Cindy L Jellis is a prominent inventor based in Londonderry, NH (US). She has made significant contributions to the field of immunology, particularly in the development of methods and compositions that target T cell proliferation and apoptosis. With a total of 3 patents to her name, her work has the potential to impact therapeutic strategies for various immune-related conditions.

Latest Patents

One of her latest patents focuses on methods of inhibiting T cell proliferation or IL-2 accumulation using CTLA-4 specific antibodies. This invention discloses isolated ligands that bind to a molecule expressed on the surface of T cells, inducing antigen-specific apoptosis in activated T cells. The patent highlights the use of a monoclonal anti-CTLA4 antibody that binds to a distinct epitope of CTLA4, leading to apoptosis when combined with an antigenic signal. Additionally, she has developed pharmaceutical compositions of anti-CTLA4 antibodies that can be administered to induce T cell apoptosis, which is crucial in transplantation and autoimmune disorders.

Another significant patent involves CTLA4-immunoglobulin fusion proteins with modified effector functions. These fusion proteins consist of a peptide with CTLA4 activity and a modified immunoglobulin constant region. The invention allows for the suppression of immune responses, which can be beneficial in preventing transplantation rejection and managing autoimmune responses.

Career Highlights

Cindy has worked with Repligen Corporation, where her innovative research has contributed to advancements in biotechnology. Her expertise in immunology and patentable inventions has established her as a key figure in her field.

Collaborations

Throughout her career, Cindy has collaborated with notable individuals such as Paul David Rennert and Gary S Gray. These partnerships have likely enhanced her research and development efforts, leading to impactful innovations.

Conclusion

Cindy L Jellis is a remarkable inventor whose work in immunology has led to significant advancements in T cell regulation and therapeutic applications. Her contributions continue to shape the landscape of immunological research and treatment strategies.